Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1
This trial looked at a new drug called DI-B4 for low grade B cell lymphoma and chronic lymphocytic leukaemia (CLL). The people taking part had lymphoma or leukaemia that was getting worse or had come back despite having other treatment.
Cancer Research UK supported this trial.
Recruitment start: 24 July 2013
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Andrew Davies
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
Merck Serono
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/12/003.
Last reviewed: 6 June 2018
CRUK internal database number: 2456
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
